Table of Content

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations


2 Executive Summary


3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions


4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges


5 Porter’s Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market


6 Global Leadless Cardiac Pacemaker Market by, Type
6.1 Overview
6.2 Micra Transcatheter Pacing System
6.3 Nanostim Leadless Cardiac Pacemaker
6.4 Wireless Cardiac Simulation System


7 Global Leadless Cardiac Pacemaker Market by, Application
7.1 Overview
7.2 Hospitals
7.3 Ambulatory Surgical Centers
7.4 Other Applications


8 Global Leadless Cardiac Pacemaker Market by, Geography
8.1 Overview
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 France
8.3.3 UK
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 South Korea
8.4.5 Australia
8.4.6 New Zealand
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Brazil
8.5.2 Argentina
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 UAE
8.6.2 Saudi Arabia
8.6.3 Qatar
8.6.4 Iran
8.6.5 South Africa
8.6.6 Rest of Middle East & Africa


9 Key Developments


10 Company Profiling
10.1 Edward Lifesciences Corporation
10.1.1 Business Overview
10.1.2 Product/Service Offering
10.1.3 Financial Overview
10.1.4 SWOT Analysis
10.1.5 Key Activities
10.2 SORIN S.p.A
10.3 Lepu Medical Technology
10.4 Vitatron
10.5 Terumo Corporation
10.6 BIOTRONIK SE & Co. KG
10.7 Boston Scientific Corporation
10.8 Medtronic Plc
10.9 EBR Systems Inc.
10.10 Abbott Laboratories Inc.
10.11 MEDICO S.p.A.
10.12 MicroPort Scientific Corporation